Acute fulminant hepatic failure (AFHF) is characterized by the rapid development of severe hepatic parenchyma injury, leading to development of jaundice, coagulopathy and hepatic encephalopathy (He) within eight weeks with previously normal liver or well-compensated liver disease. Principal etiologies include acetaminophen overdose (AOD), autoimmune hepatitis, viral hepatitis, mushroom poisoning and alcohol abuse. 1 In 15 to 20% of cases the cause is unknown.
institution of mannitol or hypertonic saline, hypothermia and, in the most severe cases, hepatic transplantation. [5] [6] [7] the molecular Adsorbents Recirculating System (mARS) may be of help in correcting biochemical derangements in the plasma. 8, 9 early detection and monitoring the course of cerebral edema is, thus, of great importance. Since coagulopathy often precludes direct measurement of intracranial pressure (ICP), we sought to determine if surrogate tests computed tomography (Ct) head scans and biochemical data) could be used to detect and monitor cerebral edema and correlated their results with mortality.
METHODS

Patient data
the University of Western Ontario ethics Review board approved our study. Our goal was to identify changes of cerebral edema on Ct and to examine Ct and baseline biochemical laboratory data with respect to patient survival. the study was retrospective but included all patients with AFHF from January 1, 2004 -January 31, 2008. We included: a) patients of 16 yearsof-age or greater who developed elevated international normalized ratio (INR) as an index of coagulopathy and encephalopathy from hepatocellular disease within eight weeks of the onset of liver disease; and b) those who had initial Ct head scans within 24 hours from admission to hospital. We excluded patients with missing data or those whose scans were delayed. We examined the patients' baseline laboratory data and Ct of brain with AFHF and graded the encephalopathy using Lockwood's grading scale (table 1) .
Computed tomography neuro-imaging analysis
the study protocol defined cerebral edema by noting specifically selected grey-white matter differentiation, ventricular size, cortical sulcal narrowing or effacement, diencephalic, uncal and tonsillar herniation, basal cistern changes, brain stem hemorrhagic changes and atrophy. the radiologist (IG) examined serial scans of each patient, noting if changes occurred. Initial and subsequent scans were then compared for each patient. Patients were assigned codes and the neuroradiologist was blinded to patient identity, but was given the patients' ages. there were no quantitative measurements. For ventricular size the scans were compared to note if the diameter of the ventricles, especially the lateral and third ventricles, decreased. Similarly, changes in the width of sulci and the distinction of grey and white matter were compared on serial scans.
Biochemical laboratory variables
We have selected the following variables: internationalized normalized ratio (INR), serum bilirubin, creatinine and albumin (SI units). these are clinically relevant laboratory variables in AFHF and are utilized by many scoring systems (model for endstage Liver Disease (meLD), King's College Hospital criteria, Pediatric end-Stage Liver disease (PeLD) and Child-turcottePugh (CtP) score) for prognostic determination [7] [8] [9] . We collected only initial (baseline) screening laboratory values for the study; all were obtained prior to starting them in medical therapy.
Statistical treatment
multivariate logistic regression was used to evaluate an association among the clinical variables obtained from Ct observations and laboratory tests. the sensitivity of various Ct parameters in showing change (cerebral edema) were compared with the grade of encephalopathy (table 1) using logistic regression analysis to create odds ratios (ORs). the comparison of various Ct parameters with each other for detecting early cerebral edema was used to create odds ratios without logistic regression. the relationships of INR and various biochemical tests to patient outcomes (survived or died) were compared using the two-tailed Student t-test. Statistical Analysis Software (SAS) 9.2 version program was used for data analysis.
RESULTS
twenty-five patients (16 were women), met our criteria; of these nine (36%) had AOD (six were women) aged 17-39 years. Other causes: alcoholic hepatitis (3), auto-immune hepatitis (1), viral hepatitis (1), multiple toxins (1) 
Neuroradiological investigation and analysis
treatment with mannitol/hypertonic saline and hypothermia was instituted as soon as cerebral edema was noted on Ct scans by the reporting radiologist on 12 of the 25 patients.
Out of 25 patients, 12 had grey-white matter differentiation (GWD) changes, changes of ventricular size and sulcal narrowing. three variables, GWD, sulcal narrowing and ventricular size showed significant changes with acetaminophen overdose.
Within the 24 hours of overdose of acetaminophen the most common changes were observed with GWD on neuroimaging studies. Grey-white matter differentiation was 34 times more likely to show changes with acetaminophen overdose patients. Patients with acetaminophen overdose were 24 times more likely to develop for cerebral edema than non acetaminophen overdose patients. Other independent variables have not shown any significant difference. the greatest number of changes observed with AOD (table 2 vs. table 3) .
Logistic regression analysis of neuroimaging results showed that AFHF patients develop the changes on brain parenchyma within 24 hours of onset of symptoms, during Grade I-II encephalopathy, most strikingly with AOD. Considering all etiologies, the ratio was 2.04 (95% CI=1.26-3.31; p < 0.004) for changes on grey-white matter differentiation over other Ct parameters (table 2) . However, with AOD, the ratio was significantly higher (OR=34.0; 95% CI=3.07-393.18; P< 0.003). there was also a significant association with AOD and 
Biochemical laboratory values
Our analysis shows that initial (baseline) total bilirubin, creatinine and albumin (all with p values > 0.05) did not have significant association with patient outcome (table 4) . However, non survivors had much lower median INR (4.8 SD +/-2.2 vs. 6.9 +/-2.6) than survivors. this apparent paradox may be explained by prompt liver transplantation in cases with markedly raised INR values. All the survivors with the AOD group had liver transplantation as the major therapeutic intervention.
DISCUSSION
Wijdicks and colleagues examined cerebral edema on Ct scans and correlated this with the severity of encephalopathy in patients with acute hepatic failure. 10 their scoring system for cerebral edema was, however, preconceived and arbitrary, giving maximal points (6) to loss of cerebral sulci. We found that loss of grey-white differentiation was as sensitive an indicator of cerebral edema. Wijdicks and colleagues rated each grey-white interface as 2 (for vertex, internal capsule and centrum semiovale), while we considered any loss of grey-white differentiation. thus, the sensitivity of Ct to encephalopathy in the system by Wijdicks et al was low until patients were in deep coma with posturing. We contend that analysis should not be so weighted, but to use the earliest features of cerebral edema. We found this to be loss of grey-white differentiation, but the interpretation relies on a qualified neuroradiologist. Our study yielded a sensitive method that correlated with and prompted Table 3 : Initial brain parenchyma changes on computed tomography for acetaminophen overdose treatment at Grade I-II encephalopathy with hyperosmolar therapy and hypothermia, and may have led to a decreased incidence of death from herniation or ischemic changes from raised intracranial pressure (ICP) and decreased perfusion pressure. baseline and subsequent Cts of brain allow for early detection of cerebral edema and may prompt steps to prevent rapid progression of cerebral edema, which has a high mortality rate. Without initial intervention at grade 1 or 2 of hepatic encephalopathy, and progression to higher grades, the probability of a good prognosis is extremely low. 6 eight of nine AOD patients developed a mild form of cerebral edema (OR=7.71; 95% CI=1.59-51.17; P< 0.004) and greywhite matter differentiation changes (OR=34.0; 95% CI=3.07-393.18; P< 0.003) during the early stages of their illness. this is noteworthy, considering that Ct of the brain is not considered as initial procedure in AOD patients. 11 Computed tomogram of head is most often used to exclude other causes of decline in mental status, such as intracranial hemorrhage or mass lesion. Our finding strongly supports performing a Ct head scan on AOD patients as soon as they are admitted, to serve as a baseline for subsequent scans. Recognizing specific changes provides an opportunity to prevent the progression of severe form of cerebral edema ( Figures A-C) . Acetaminophen overdose cases may constitute a special group at risk of developing cerebral edema earlier in the course of AFHF. this is supported by a study in rats, in which acetaminophen produced more marked cerebral cortical edema than was found in rats with hyperammonemia from partial portal vein ligation. 12 Although the American Association for the Study of Liver Diseases recommends ICP monitoring for AFHF 11 , such invasive monitoring is associated with intracerebral hemorrhages in 10-20% of cases 13 . Intracranial pressure monitoring procedure becomes virtually impossible to perform on patients with high INR. Furthermore, the 30 day survival rate was the same in monitored compared to unmonitored patients in a retrospective survey 13 . the ICP monitoring is invasive and is usually performed in patients with Grade III-Iv encephalopathy, in whom cerebral edema is present in 75 to 80% of patients 13 .
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When the brain is markedly swollen, successful intervention is less effective than in Stage I-II. 13 Raised ICP indicates that the compensatory mechanisms have been exhausted and impairment of brain perfusion and herniation are imminent.
Noninvasive methods for determining intracranial pressure, notably transcranial Doppler using the pulsatility index have some value, but are inaccurate over a wide range of values and suffer the same limitations as direct ICP monitoring as an "early warning system" for detecting cerebral edema. 14 early sequential Ct scans can be valuable diagnostic tool for patients who have significantly high level of INR or uncontrollable coagulopathy while waiting for liver transplantation. (thus, we suggest that early and sequential Ct scans are more sensitive than Ct for cerebral edema and risk of serious progression). Computed tomogram can be used pre-emptively to institute treatment to offset severe cerebral edema and the risk of ischemia and herniation.
Strengths and limitations of the study this study carries significant strength clinically. early Ct scans (within 24 hour) are sensitive to early brain parenchyma changes as shown by grey-white interface changes on initial Ct scans. the results are more robust and predictive than hematological and biochemical tests. Initial and serial Ct scans may obviate the need for ICP monitoring, which is often instituted too late in the illness in any case. Furthermore many patients cannot safely have ICP monitoring or decompression because of severe coagulopathy and systemic illness.
Our study is limited by its small sample size and retrospective nature. Few patients had serial Ct scans. Ideally a multi-centre prospective study could be used to determine optimal monitoring and therapeutic strategies.
